The trademark CARDIOCINE was filed by Teva Pharmaceuticals Europe B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on October 19, 2023, and received one opposition filed on January 16, 2024 by Egis Gyógyszergyár Zrt. on Likelihood of confusion. the opponent was represented by Szentesi, Orsolya and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 16, 2024
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).